Is Your Doctor Being Stalked?

According to a shocking abstract presented at the American Psychiatric Association's annual meeting, over 20 percent of doctors report having been stalked by a patient or a former patient at some time.

Out of about 600 doctors, 123 of them reported that they have had a patient performed one or more stalking behaviors on at least three occasions, according to Kathleen C. Dougherty, MD, of Penn State University Medical Center in Hershey, Pa.

Dougherty administered a survey to 1100 doctors from two medical centers in Pennsylvania to get the results.

Stalking was divvied into 10 individual behaviors:

-- Spying or surveillance
-- Following
-- Loitering
-- Unwanted personal approaches
-- Unwanted phone calls at work or home
-- Unwanted written communications
-- Sending offensive material
-- Ordering or cancelling goods or services
-- Spreading rumors or making false reports
-- Interfering with property.

As one can see, these behaviors are somewhat subjective. Nonetheless, almost 40 percent reported experiencing at least one of the behaviors. Female doctors were stalked with the same frequency as men, but female doctors tended to have male stalkers, whereas male doctors had both male and female stalkers.

One doctor said that he'd had a loaded gun put to his head by one patient, although most of the time doctors could not determine what their stalker's motivation was.

Source: Medpage Today

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap